• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Immunol Methods . Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects

tetano

Editor, Senior Moderator
J Immunol Methods


. 2021 Nov 26;113197.
doi: 10.1016/j.jim.2021.113197. Online ahead of print.
Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects


Alessandro Manenti[SUP] 1 [/SUP], Elena Gianchecchi[SUP] 2 [/SUP], Francesca Dapporto[SUP] 3 [/SUP], Margherita Leonardi[SUP] 3 [/SUP], Paolo Cantaloni[SUP] 2 [/SUP], Filippo Fattorini[SUP] 2 [/SUP], Pietro Piu[SUP] 2 [/SUP], Valentina Bollati[SUP] 4 [/SUP], Ugo Pastorino[SUP] 5 [/SUP], Giovanni Apolone[SUP] 5 [/SUP], Gabriella Sozzi[SUP] 5 [/SUP], Emanuele Montomoli[SUP] 6 [/SUP]



Affiliations

Abstract

Since the first detection of a novel Coronavirus (SARS-CoV-2) in December 2019 in Wuhan (China), it has become crucial to assess and quantize the human humoral immune response after SARS-CoV-2 natural infection and/or vaccination. Having well standardized and reliable serological assays able to accurately measure the total IgG antibodies response as well as the neutralization dynamics, play a pivotal role for the evaluation of "second" and "third" vaccines generation and in monitoring the effect in case of reinfection in the human population caused by the original strains or new SARS-CoV-2 variants. In the present study we reported that both symptomatic convalescent and vaccinated donors showed the presence of different levels of neutralizing antibodies. In addition, vaccinated subjects presented high levels of anti-S antibodies, whereas the complete absence of anti-N antibodies, whereas convalescent patients presented high levels of both anti-S and anti-N antibodies. The evaluation of the correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects revealed that the IgG anti-S log-values were significantly higher in the vaccinated group respect to convalescent subjects. In addition, the level of binding antibodies recognizing the S protein shows a positive linear regression when compared to neutralizing titres in both the two groups evaluated.

Keywords: Anti-S antibodies; Neutralizing antibodies; SARS-CoV-2; SARS-CoV-2 vaccine.
 
Back
Top Bottom